Health insurer Humana is partnering with Revon Systems, a Louisville, KY-based digital health startup on a market-wide pilot for a select population of Medicare Advantage members diagnosed with chronic obstructive pulmonary disease (COPD). Rveon has developed smart symptom tracking technology in asthma and COPD.
Revon believes that early intelligent interpretation and feedback of data to patients leads to better control of chronic diseases that “flare up” or exacerbate such as COPD, Asthma and many others.
Smart Symptom Pilot Program Details
The program seeks to evaluate the impact of digital therapies on clinical and business outcomes. This involves the use of the Revon Smart Symptom Tracker (RSST) mobile app and the free Breathe COPD Resource Kit, which contains a pulse oximeter and thermometer.
The RSST app features a self-triage function intended to guide members toward the right level of care. Recommendations from the RSST guide users to take the appropriate early action on the basis of their symptoms, signs, and personal baseline health.
Understanding Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD) is a chronic lung condition and the third leading cause of death in the United States. 10.3% of Kentucky residents report having a COPD diagnosis. COPD, once deemed to be a disease with a hopeless prognosis, is now known to be very treatable. Early diagnosis and treatment can enable people with COPD to take charge of their breathing and regain control of their lives. Common treatment goals include becoming more active, decreasing shortness of breath, and lowering of anxiety and depression.
“We are pleased to work with Humana on their Bold Goal to reduce chronic disease by 20% by 2020. We know that COPD can be a challenge for patients to manage, and we hope that Revon’s Smart Symptom Tracker technology will result in more Healthy Days for the participating members,” said Ted Smith, Ph.D., and Chief Executive Officer of Revon System in a statement.
